Plot No.367, Abhey Pur, Industrial Area Phase-1, Panchkula, Haryana 134109
Don't miss out on this limited-time offer to join our successful PCD Pharma network. Fill in your details below and our team will get in touch with you to discuss the best franchise opportunities tailored to your needs.
Polmacoxib (2mg)
Therapeutic Category
Anti-Inflammatories, Analgesics
Dosage Form
Capsule
Packaging Type
Strip
Packaging
10*10
Price
₹248/-
High-resolution images and Product visuals
Product overview and usage information
Detailed information and research documents
Plomatch Capsule contains Polmacoxib, a highly effective selective COX-2 inhibitor that is used primarily for managing pain and inflammation. Polmacoxib works by selectively inhibiting the cyclooxygenase-2 (COX-2) enzyme, which plays a key role in the production of pro-inflammatory prostaglandins. By targeting COX-2 specifically, it helps reduce inflammation and pain while minimizing the gastrointestinal side effects commonly associated with non-selective NSAIDs.
This medication is particularly effective in the treatment of osteoarthritis and rheumatoid arthritis, offering relief from pain, swelling, and stiffness in affected joints. It is also beneficial for other inflammatory conditions requiring long-term pain management. The once-daily dosing regimen of Plomalix Capsule ensures consistent pain relief and improved patient compliance.
Polmacoxib is an advanced therapy option due to its ability to combine efficacy with a favorable safety profile, making it suitable for patients who may have concerns about traditional NSAIDs' adverse effects.
Possible side effects include dizziness, headache, abdominal discomfort, or mild nausea. Rarely, hypersensitivity reactions or cardiovascular effects may occur.
Plomatch Capsule is indicated for the treatment of osteoarthritis, rheumatoid arthritis, and other conditions associated with pain and inflammation.
Use only under medical supervision. Inform your healthcare provider of any pre-existing conditions, especially cardiovascular, gastrointestinal, or kidney issues, before starting the medication.
Store in a cool, dry place, away from direct sunlight and moisture. Keep out of reach of children.
Composition : Indomethacin (75mg)
Composition : Piroxicam (20mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Trypsin Chymotrypsin (50000AU)
Composition : Diclofenac (100mg)
Composition : Diclofenac (50mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg) + Serratiopeptidase (10mg)
Composition : Diclofenac (50mg) + Paracetamol (325mg)
Composition : Diclofenac (50mg) + Metaxalone (400mg)
Composition : Diclofenac (75mg/ml)
Composition : Piroxicam (20mg) Injection
This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.
Polmacoxib 2 mg Capsule is a selective COX-2 inhibitor NSAID formulation used for the management of osteoarthritis-related pain, inflammation, joint stiffness, and chronic musculoskeletal disorders. It provides effective pain relief with a reduced risk of gastrointestinal side effects compared to traditional NSAIDs. It is a valuable orthopedic and pain management segment product for medical distributors, wholesalers, and pharma franchise partners in the PCD pharma pharma franchise market.
Medical distributors and wholesalers can benefit from consistent demand from orthopedic specialists, rheumatologists, pain clinics, and general physicians. Arthritis and joint disorders are highly prevalent, especially in aging populations, ensuring regular prescriptions, chronic therapy usage, and stable long-term market demand.
Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities in the orthopedic, anti-inflammatory, and chronic pain management segments with monopoly rights, quality manufacturing standards, promotional support, and reliable supply services for distributors and medical agencies.
Wholesalers and healthcare suppliers benefit from high chronic prescription cycles, strong orthopedic market demand, improved patient compliance therapies, and continuous retail consumption, making it a stable and high-value pharmaceutical category when partnered with Cafoli Lifecare.
Medical distributors, stockists, and pharma professionals interested in orthopedic and chronic pain management formulations can contact Cafoli Lifecare to discuss product availability, pricing structure, and PCD pharma franchise opportunities in the pain management segment.